🎉 Finosauras is now  SarasRead more
Concord Biotech Ltd logo

Concord Biotech Ltd - Share Price Target 2026

(NSE: CONCORDBIO)

Sector: Healthcare

Market Cap: 1519341.13 Lakh Cr

1841.60

-

1599.20

Target Price Range

1351.00

-0.10 (-0.01%)

CMP

Bearish

As on 16 Jan 2026, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish1
Bearish3
Neutral2
Agg. Profit Potential7.70%
Agg. Risk 28.19%

Last updated on: 17/01/2026, 9:47 am

Returns

PeriodReturn %
1 Month-16.64
3 Months-29.43
1 Year-25.94
5 Years--

Last updated on: 06/09/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
Government Pension Fund Global2.74%2,868,248
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap Fund1.95%2,042,886
Axis Max Life Insurance Limited A/C Reversionary Bonus Participating - Equity1.52%1,584,988

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

42.52

P/B Ratio

8.19

PEG Ratio

2.10

ROE

22.35%

EPS

34.15

Dividend Yield

0.74%

Market Cap

1519341.13 Lakh Cr

Sector

N/A

Last Updated: 12 Nov 2025, 01:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Concord Biotech Ltd.

Incorporated Year

1984

City and State

Ahmedabad Dist, Gujarat

Listing Date

Director's Name

Prakash Sajnani

Revenue

1.20 Lakh Cr

Net Profit

49587.54 Cr